Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management
Avoid skipping doses, drastically overeating, or relying on semaglutide alone without healthy lifestyle habits
Ozempic and Rybelsus are two other brands of semaglutide on the market that are approved by the FDA for glycemic control in diabetes but not for weight management
But generally, its not a side effect reported in the larger phase 3 trials
In addition to losing weight, you may also experience lower blood sugar levels (without hypoglycemia), better insulin synthesis, a more satisfied appetite, and improvement in cardiovascular risk factors
Beyond 12 months: maintenance phase The SURMOUNT-4 trial clearly showed that ongoing tirzepatide treatment maintains weight loss, while discontinuation leads to regain